Healthcare Moves: A Monthly Summary of Hires and Layoffs
Here is a selection of recent executive hires, promotions and layoffs occurring across the healthcare industry.
Healthcare Moves: A Monthly Summary of Hires and Layoffs
Here is a selection of recent executive hires, exits, promotions and layoffs occurring across the healthcare industry.
Check out video highlights of INVEST Precision Medicine conference from pediatrics to funding trends
The INVEST Precision Medicine conference cast a spotlight on the role of children's hospitals, biopharma companies, diagnostic companies and startups in biopharma innovation. The video recordings of the conference sessions are now available to view.
INVEST Precision Medicine Conference Video: Pediatrics and Precision Medicine
A panel of precision medicine experts from Children’s hospitals take part in a conversation that highlights the work being done to improve the way rare diseases and pediatric cancer is diagnosed and treated.
As children’s hospitals build up precision medicine programs, families still face challenges in reaching a diagnosis
Children's hospitals are launching big efforts to identify more rare diseases through genome sequencing. Even as new treatments become available, many families struggle to reach a diagnosis.
INVEST Precision Medicine conference kicks off today. Register now to be part of the conversation.
Register for the INVEST Precision Medicine conference, which kicks off today. Over the next three days industry experts will talk about precision medicine developments across pediatrics, bioinformatics, startups and more.
A Deep-dive Into Specialty Pharma
A specialty drug is a class of prescription medications used to treat complex, chronic or rare medical conditions. Although this classification was originally intended to define the treatment of rare, also termed “orphan” diseases, affecting fewer than 200,000 people in the US, more recently, specialty drugs have emerged as the cornerstone of treatment for chronic and complex diseases such as cancer, autoimmune conditions, diabetes, hepatitis C, and HIV/AIDS.
Register for INVEST Precision Medicine virtual conference June 9-11 where life science and health tech meet
The conference will include conversations with healthcare industry experts from The Steve & Cindy Rasmussen Institute for Genomic Medicine, Nationwide Children's Hospital, Vineti, Ori Biotech, CVS Caremark, Caris Life Sciences, HHS, University City Science Center, and more.
Startup offering medical second opinion service partners with Boston Children’s, Nationwide Children’s
Patients using the offering from the startup, MORE Health, can get access to physicians and services at Boston Children's Hospital and Nationwide Children's Hospital.
Audentes, Nationwide Children’s to develop gene therapy in Duchenne muscular dystrophy
An analyst wrote that the therapy's combination of AAV delivery with a validated means of treating DMD could distinguish it from other gene therapies in what is already a crowded space.
Fresh off first FDA approval, Amicus spends $100M to acquire 10 gene therapies
The company acquired 10 AAV-based gene therapies in development for lysosomal storage disorders, including two already in early clinical trials.
With the Rise of AI, What IP Disputes in Healthcare Are Likely to Emerge?
Munck Wilson Mandala Partner Greg Howison shared his perspective on some of the legal ramifications around AI, IP, connected devices and the data they generate, in response to emailed questions.
Apps help emergency rooms offer shared decision-making
Mobile apps are helping to accelerate the shift.
Nationwide Children’s spinoff GenomeNext raises $1.2M seed round
The funding will support expanded commercial and operational capacity and product development,
Is Nationwide Children’s physician noncompete clause too onerous?
An investigation by the Columbus Dispatch revealed that Nationwide Children's bans employed pediatric specialists from taking jobs within 100 miles of the hospital within two years of leaving. That rules out Cincinnati and Dayton, but not Cleveland.
Quartet of advocacy groups seed an Ohio startup’s gene therapy for rare Sanfilippo syndrome
A Cleveland biotech startup focused on a rare genetic disease provides an interesting example of the growth of alternative funding for life science companies. Abeona Therapeutics’ just-announced $750,000 seed round, which will allow the startup to complete preclinical development of gene therapies for Sanfilippo syndrome, came not from angel or venture capital investors but from […]
Sharing is caring: Pediatric hospitals find working together a necessity for innovation, commercialization
Children’s hospital leaders in Ohio recently brought to light an “unlimited supply” of unsolved problems in pediatrics that certainly isn’t going to solve itself. In response, they and others have increasingly turned to collaboration to bring new medical treatments to children. In Ohio, six children’s hospitals have banded together under the Ohio Children’s Hospital Association, […]